Savior Lifetec Corporation

TPEX:4167 Stock Report

Market Cap: NT$6.5b

Savior Lifetec Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Savior Lifetec.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth59.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is Savior Lifetec (GTSM:4167) Using Too Much Debt?

Mar 29
Is Savior Lifetec (GTSM:4167) Using Too Much Debt?

Update: Savior Lifetec (GTSM:4167) Stock Gained 35% In The Last Five Years

Feb 22
Update: Savior Lifetec (GTSM:4167) Stock Gained 35% In The Last Five Years

Savior Lifetec Corporation (GTSM:4167) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Jan 25
Savior Lifetec Corporation (GTSM:4167) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Should You Use Savior Lifetec's (GTSM:4167) Statutory Earnings To Analyse It?

Dec 29
Should You Use Savior Lifetec's (GTSM:4167) Statutory Earnings To Analyse It?

Savior Lifetec (GTSM:4167) Seems To Use Debt Quite Sensibly

Dec 03
Savior Lifetec (GTSM:4167) Seems To Use Debt Quite Sensibly

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Savior Lifetec has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:4167 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20241,258180404475N/A
6/30/20241,213121460503N/A
3/31/20241,088104450491N/A
12/31/20231,05030370388N/A
9/30/2023986-55282297N/A
6/30/20231,04794520538N/A
3/31/20231,18088472500N/A
12/31/20221,26636548582N/A
9/30/20221,34748534583N/A
6/30/20221,378-142186243N/A
3/31/20221,545-124-2842N/A
12/31/20211,74410-264-168N/A
9/30/20211,976131-394-248N/A
6/30/20212,026233-369-207N/A
3/31/20211,904240-1861N/A
12/31/20201,827251-12591N/A
9/30/20201,63620134251N/A
6/30/20201,5481586247N/A
3/31/20201,450100104331N/A
12/31/20191,319-5-43156N/A
9/30/20191,194-1599176N/A
6/30/20191,113-257-206-46N/A
3/31/20191,122-275-365-188N/A
12/31/20181,105-360-394-190N/A
9/30/20181,173-300-418-224N/A
6/30/20181,302-187N/A-2N/A
3/31/20181,432-89N/A104N/A
12/31/20171,61822N/A261N/A
9/30/20171,78195N/A272N/A
6/30/20171,80130N/A158N/A
3/31/20171,704-77N/A5N/A
12/31/20161,532-208N/A-76N/A
9/30/20161,303-389N/A-266N/A
6/30/20161,185-457N/A-404N/A
3/31/20161,127-494N/A-444N/A
12/31/20151,121-494N/A-416N/A
9/30/20151,195-424N/A-245N/A
6/30/20151,119-443N/A-181N/A
3/31/20151,081-401N/A-143N/A
12/31/20141,019-356N/A-92N/A
9/30/2014933-343N/A-180N/A
6/30/2014961-245N/A-217N/A
3/31/2014968-245N/A-199N/A
12/31/20131,001-229N/A-186N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4167's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if 4167's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4167's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4167's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4167's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 4167's Return on Equity is forecast to be high in 3 years time


Discover growth companies